Want to see AU:WNX full AI Analyst Report?

Wellnex Life Ltd (WNX) Price & Analysis

8 Followers

WNX Stock Chart & Stats

AU$0.09

AU$0.01(1.47%)

At close: Jan 09 4:00 PM EST

AU$0.09

AU$0.01(1.47%)

Day’s Range― - ―

52-Week RangeAU$0.04 - AU$0.32

Previous CloseN/A

Volume2.27K

Average Volume (3M)51.95K

Market Cap

AU$3.65M

Enterprise ValueAU$12.64M

Total Cash (Recent Filing)AU$975.00K

Total Debt (Recent Filing)AU$10.03M

Price to Earnings (P/E)―

Beta1.23

Next Earnings

Aug 28, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.28

Shares Outstanding73,026,810

10 Day Avg. Volume31,968

30 Day Avg. Volume51,946

Financial Highlights & Ratios

PEG Ratio0.01

Price to Book (P/B)0.69

Price to Sales (P/S)0.33

P/FCF Ratio-11.64

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.05

Revenue Forecast (FY)AU$48.60M

Bulls Say, Bears Say

Bulls Say

Manageable LeverageA moderate debt-to-equity ratio (0.48) provides financial flexibility and lowers immediate solvency risk, supporting the company's ability to fund product development and distribution initiatives without excessive interest burden. This structural leverage level helps preserve runway while pursuing growth.

Positive Gross Margin On ProductsA positive gross profit margin shows product economics can cover direct manufacturing and packaging costs, a durable advantage for consumer healthcare goods. If overheads and marketing are managed, unit-level margins enable scalable profitability as volumes increase and distribution expands over months.

Consistent Modest Revenue GrowthMid-single-digit revenue growth reflects persistent end-customer demand and some distribution traction. That steady top-line expansion provides a platform to improve operating leverage and amortize fixed costs over time, supporting a path to stronger margins if growth continues.

Bears Say

Ongoing UnprofitabilitySustained negative EBIT and net profit margins undermine internal capital generation and signal core profitability issues. Persistent operating losses reduce retained earnings and force reliance on external funding, constraining strategic investments and raising execution risk over the medium term.

Negative Operating And Free Cash FlowNegative operating and free cash flows, plus a deteriorating free cash flow trend, indicate the business is not generating sufficient cash to fund operations or growth. This structural cash generation shortfall increases financing needs and limits ability to scale marketing or inventory investments.

Negative Return On EquityA negative ROE shows shareholder capital is not producing returns, reflecting poor capital allocation or subscale operations. Over months this erodes investor value and reduces the company's ability to attract low-cost capital, making sustained growth and investment more difficult.

Wellnex Life Ltd News

Wellnex Life strengthens board with appointment of veteran banker Hilton Wood

Wellnex Life Ltd ( ($AU:WNX) ) has issued an update. Wellnex Life Limited has appointed banking veteran Hilton...

21d ago

Wellnex Life Turns Cash-Flow Positive as Turnaround Gains Traction

Wellnex Life Ltd ( ($AU:WNX) ) has issued an update. Wellnex Life reported a milestone March quarter, delivering...

2M ago

Wellnex Life Extends Director Loan Repayment and Re-engages Former CEO as Consultant

The latest announcement is out from Wellnex Life Ltd ( ($AU:WNX) ). Wellnex Life Limited has renegotiated the...

2M ago

Wellnex Life Seeks Extension on $2.88m Loan Repayment from Former Directors

Wellnex Life Ltd ( ($AU:WNX) ) just unveiled an announcement. Wellnex Life Limited, a dual-listed health and wellness...

2M ago

Wellnex Life Options Lapse, Trimming Potential Equity Dilution

Wellnex Life Ltd ( ($AU:WNX) ) has issued an announcement. Wellnex Life Ltd has reported the cessation of...

3M ago

Wellnex Life Issues New Shares as It Weighs Value-Creation Opportunities

Wellnex Life Ltd ( ($AU:WNX) ) has shared an update. Wellnex Life Limited has issued 3,071,336 fully paid...

3M ago

Wellnex Life Seeks ASX Quotation for Over 3 Million New Shares

An announcement from Wellnex Life Ltd ( ($AU:WNX) ) is now available. Wellnex Life has applied for quotation...

3M ago

Wellnex Life Extends Haleon Paracetamol Supply Deal to 2027

Wellnex Life Ltd ( ($AU:WNX) ) just unveiled an update. Wellnex Life has extended its licensing and supply...

3M ago

Wellnex Life Plans Equity Placement of Over 3 Million Shares

The latest announcement is out from Wellnex Life Ltd ( ($AU:WNX) ). Wellnex Life has notified the ASX...

3M ago

Wellnex Life Issues New Shares to Settle Advisory Fees and Updates Capital Base

Wellnex Life Ltd ( ($AU:WNX) ) has provided an update. Wellnex Life Limited has issued 3,071,336 fully paid...

3M ago

WNX FAQ

What was Wellnex Life Ltd’s price range in the past 12 months?

Wellnex Life Ltd lowest share price was AU$0.04 and its highest was AU$0.32 in the past 12 months.

What is Wellnex Life Ltd’s market cap?

Wellnex Life Ltd’s market cap is AU$3.65M.

When is Wellnex Life Ltd’s upcoming earnings report date?

Wellnex Life Ltd’s upcoming earnings report date is Aug 28, 2026 which is in 56 days.

How were Wellnex Life Ltd’s earnings last quarter?

Wellnex Life Ltd released its earnings results on Feb 26, 2026. The company reported -AU$0.026 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.026.

Is Wellnex Life Ltd overvalued?

According to Wall Street analysts Wellnex Life Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Wellnex Life Ltd pay dividends?

Wellnex Life Ltd does not currently pay dividends.

What is Wellnex Life Ltd’s EPS estimate?

Wellnex Life Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Wellnex Life Ltd have?

Wellnex Life Ltd has 73,026,810 shares outstanding.

What happened to Wellnex Life Ltd’s price movement after its last earnings report?

Wellnex Life Ltd reported an EPS of -AU$0.026 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Wellnex Life Ltd?

Currently, no hedge funds are holding shares in AU:WNX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Wellnex Life Ltd Stock Smart Score

Underperform

Blogger Sentiment

Bearish

AU:WNX Sentiment 100%
Sector Average ―

Technicals

Fundamentals

Return on Equity

-92.72%

Trailing 12-Months

Asset Growth

-17.21%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Wellnex Life Ltd

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.